Its transcription is upregulated in obese individuals with severe NAFLD (particularly in carriers of the PNPLA3 I148M risk variant) and can be induced by lipotoxicity in hepatocytes [135]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.